Invivyd, Inc. Invivyd, Inc.

Invivyd, Inc.

IVVD

Rank in Stocks #17035
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development... Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
Share Price
$0.5673
Last synced: 2026-11-12
Market Cap
$181.78M
Change (1 day)
-5.34%
Change (1 year)
-77.58%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Invivyd, Inc. (IVVD)
Operating Margin as of November 2026 TTM: -192.81%
According to Invivyd, Inc.'s latest financial reports, its current operating margin (TTM) is -192.81%. At the end of 2025 the company had an operating margin of -103.99%.
Operating Margin history for Invivyd, Inc. from 2020 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -192.81% 85.41%
2025 -103.99% -85.08%
2024 -696.80% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
-195.39% -98.99%
US
33.87% -100.18%
US
-116.04% -99.40%
US
25.57% -100.13%
AU
31.23% -100.16%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Invivyd, Inc.'s operating margin

What is Invivyd, Inc.'s operating margin?

Invivyd, Inc.'s operating margin is -192.81%, as of Nov 2026.

What was Invivyd, Inc.'s operating margin in 2025?

In 2025, Invivyd, Inc.'s operating margin was -103.99%, compared with -696.80% in 2024.

How has Invivyd, Inc.'s operating margin changed since 2020?

From 2020 to 2025, Invivyd, Inc.'s operating margin was highest in 2023 (0.00%) and lowest in 2024 (-696.80%).

How does Invivyd, Inc.'s operating margin compare with similar companies?

Invivyd, Inc.'s operating margin (-192.81%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.